Live Breaking News & Updates on செக்மேட் மருந்துகள்
Stay updated with breaking news from செக்மேட் மருந்துகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EVP and CFO of Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI), Krieg Arthur M, buys 443 shares worth $6,273 According to Checkmate Pharmaceuticals, Inc. s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 31 04:20 PM, company EVP and CFO, Krieg Arthur M disclosed buying 443 shares at a cost of $14.16. At the time of this transaction (Dec 29), this trade was worth $6,273 in total. As of Dec 29, Krieg Arthur M now owns 730,990 shares in total worth about $10,665,144.1. For the last few recent trades made by Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI) EVP and CFO, Krieg Arthur M, we have the following information: ....
Aclaris Therapeutics (NASDAQ:ACRS), iShares Diversified Alternatives Trust ETF (ETF:ALT) - 12 Health Care Stocks Moving In Wednesday's After-Market Session benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.